Literature DB >> 26127005

The role of vitamin D towards immune tolerance in white adipose tissue (WAT).

Salvatore Chirumbolo1.   

Abstract

Vitamin D and its active form 1α,25(OH)2D3 has been recently indicated to have a fundamental role in immune regulation. An interplay between gut and white adipose tissue (WAT), mainly mediated by enterogastric hormones and adipokines, such as leptin, adiponectin and ghrelin, actively participate in the immune homeostasis and modulation both of the innate/acquired immune response and between T-cell effector/T-cell regulatory skewing. Particularly for leptin, this action promotes and enhances immune tolerance at the gut level and pro-inflammatory effect at WAT level, while calcitriol participates in promoting and increasing an M2 macrophage-like skewing, a T-reg activity at WAT level and a iNKT function at gut level. The role of active vitamin D3 therefore is fundamental in the immune homeostasis of the WAT immune microenvironment and to support the role of WAT as an endocrine, tolerogenic organ.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26127005     DOI: 10.2174/1871530315666150701113811

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  3 in total

Review 1.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Vitamin D Deficiency in Primary Sjögren's Syndrome: Association with Clinical Manifestations and Immune Activation Markers.

Authors:  Panagiotis Athanassiou; Clio Mavragani; Lambros Athanassiou; Ifigenia Kostoglou-Athanassiou; Michael Koutsilieris
Journal:  Mediterr J Rheumatol       Date:  2022-03-31

3.  Vitamin D in acutely ill patients.

Authors:  Ifigenia Kostoglou-Athanassiou; Eleni Pantazi; Sofoklis Kontogiannis; Dimitrios Kousouris; Iordanis Mavropoulos; Panagiotis Athanassiou
Journal:  J Int Med Res       Date:  2018-08-29       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.